Dr. Shelley Deeks, MD, MHSc, FRCPC, FFAFPM, is a Canadian public health expert who is the chair of the National Advisory Committee on Immunization.
[1] Her advertised "specialities include communicable disease control, outbreak investigations, vaccine safety, epidemiology and program evaluation."
"[2] In reality, she was not consulted in November 2020 "on colour-coded COVID restrictions", and two days after the revelations the Ford government moved to bring the colour codes into line with PHO's recommendations.
[6] On 29 March 2021, as vice-chair of NACI, Deeks said that "There is substantial uncertainty about the benefit of providing AstraZeneca COVID-19 vaccines to adults under 55 given the potential risks."
[16] She assisted the Nova Scotia Department of Health and Wellness in a promotion campaign for the vaccine program, including encouraging second doses to protect against new variants of COVID-19 and reassuring viewers that side effects are rare and well-tolerated.
[24] Sigvaria developed ImmunizeCA, a smartphone application with various vaccine-related capabilities resembling an early version of a digital vaccine passport.
[25][26] Deeks is the co-investigator of an ongoing Canadian Institutes of Health Research (CIHR) grant-funded study investigating Ontario's preparedness for the return of measles.
[31] Deeks is a principal investigator in the Canadian Immunization Research Network's "COVID-19 Vaccine Readiness" program at Dalhousie University, funded by a $3,516,000 grant from the Public Health Agency of Canada.